Preferred Label : CMV pp65 Peptide-pulsed Autologous Dendritic Cell Vaccine;
NCIt synonyms : CMV pp65 Peptide-pulsed Autologous DC Vaccine;
NCIt definition : A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with
the human cytomegalovirus (CMV) phosphoprotein pp65, with potential immunostimulatory
and antineoplastic activities. Upon administration, the CMV pp65 peptide-pulsed autologous
DC vaccine exposes the immune system to the CMV pp65 peptide, which may result in
a cytotoxic T-lymphocyte (CTL) response against CMV pp65-expressing tumor cells leading
to cell lysis. The CMV pp65 protein, also called the 65 kDa lower matrix phosphoprotein,
is the primary component of the enveloped subviral particle of CMV and is expressed
in certain tumor types, such as glioblastoma.;
NCI Metathesaurus CUI : CL421597;
Origin ID : C116740;
UMLS CUI : C3899758;
Semantic type(s)
- concept_is_in_subset
- has_target
